BioDelivery Sciences International Inc
NASDAQ:BDSI
BioDelivery Sciences International Inc
Interest Income Expense
BioDelivery Sciences International Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioDelivery Sciences International Inc
NASDAQ:BDSI
|
Interest Income Expense
-$7.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$212m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$676m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$1.5B
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-13%
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$368m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-30%
|
See Also
What is BioDelivery Sciences International Inc's Interest Income Expense?
Interest Income Expense
-7.1m
USD
Based on the financial report for Dec 31, 2021, BioDelivery Sciences International Inc's Interest Income Expense amounts to -7.1m USD.
What is BioDelivery Sciences International Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-16%
Over the last year, the Interest Income Expense growth was -1%. The average annual Interest Income Expense growth rates for BioDelivery Sciences International Inc have been 6% over the past three years , -16% over the past five years .